REVB
REVELATION BIOSCIENCES, INC.
+0.01 (+1.41%)0.93USD8.9K成交股數3.7M市值0.0本益比(近四季)–股價營收比+317.6%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 82K+318% | – | – | – | 20K | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.9M | 1.4M | 964K | 923K | 1.3M | 859K | 831K | 1.4M | 718K | 1.1M | 1.7M | 909K |
| 銷售管理費用 | 1.7M | 1.7M | 1.6M | 1.0M | 1.1M | 1.2M | 966K | 1.1M | 1.2M | 1.3M | 1.1M | 1.0M |
| 營業利益 | −3.7M+49% | −3.1M+48% | −2.6M+43% | −1.9M-23% | −2.5M+29% | −2.1M-10% | −1.8M-35% | −2.5M+30% | −1.9M | −2.3M | −2.8M | −1.9M |
| 營業利益率 | -4,457.5% | – | – | – | -12,511.3% | – | – | – | – | – | – | – |
| 稅後淨利 | −3.3M+36% | −3.0M+47% | −2.5M+12% | −1.9M-77% | −2.4M-9% | −2.1M-7% | −2.2M-15% | −8.4M+479% | −2.7M | −2.2M | −2.6M | −1.4M |
| 淨利率 | -4,045.1% | – | – | – | -12,425.7% | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.87-97% | -2.71-89% | 31.20-178% | -1.77-99% | -28.04-29% | -25.34-15% | -40.15+304% | -246.27+4124% | -39.37 | -29.74 | -9.94 | -5.83 |
| 稀釋股數 | 3.8M | 3.2M | 621K | 2.6M | 201K | 80.9K | 55.8K | 34.1K | 68.1K | 14.2K | 265K | 248K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 11.5M | 14.1M | 10.7M | 12.7M | 5.2M | 3.7M | 6.5M | 12.1M | 14.6M | 12.0M | 14.0M | 15.7M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 12.5M | 15.0M | 11.6M | 12.9M | 5.4M | 4.0M | 6.7M | 12.3M | 14.7M | 12.2M | 14.2M | 16.0M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 2.4M | 2.1M | 2.7M | 1.9M | 1.6M | 1.1M | 4.1M | 11.1M | 5.2M | 5.6M | 5.4M | 4.6M |
| 股東權益 | 10.1M | 13.0M | 8.9M | 11.0M | 3.8M | 2.9M | 2.7M | 1.1M | 9.5M | 6.6M | 8.8M | 11.4M |
| 負債比 | 19.5% | 13.7% | 23.5% | 14.4% | 29.1% | 27.4% | 60.3% | 90.7% | 35.6% | 45.6% | 38.0% | 28.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.2M+15% | – | – | – | −2.8M | – | – | −2.8M | – | – | – |
| 資本支出 | – | 72K | – | – | – | – | – | – | 19K | – | – | – |
| 自由現金流 | – | −3.3M | – | – | – | – | – | – | −2.9M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −8.9M | –% | -23.95 | – |
| FY2024 | – | – | −15.0M | –% | -1052.16 | −18.3M |
| FY2023 | – | – | −120K | –% | -8.44 | – |
| FY2022 | – | – | −10.8M | –% | -149.20 | – |
| FY2021 | – | – | −12.0M | –% | -42.50 | −11.2M |
| FY2020 | – | – | −1.6M | –% | -0.68 | – |
| FY2019 | – | – | −4K | –% | – | – |